Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
July 2, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-005516.pdf 0001562180-24-005516.rtf 0001562180-24-005516.xls View HTML
June 26, 2024	3	Initial filing by director officer or owner of more than ten percent	0001562180-24-005321.pdf 0001562180-24-005321.rtf 0001562180-24-005321.xls View HTML
June 24, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000059.pdf 0001517022-24-000059.rtf 0001517022-24-000059.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 10, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000057.pdf 0001517022-24-000057.rtf 0001517022-24-000057.xls View HTML
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004904.pdf 0001562180-24-004904.rtf 0001562180-24-004904.xls View HTML
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004901.pdf 0001562180-24-004901.rtf 0001562180-24-004901.xls View HTML
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004905.pdf 0001562180-24-004905.rtf 0001562180-24-004905.xls View HTML
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004909.pdf 0001562180-24-004909.rtf 0001562180-24-004909.xls View HTML
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004906.pdf 0001562180-24-004906.rtf 0001562180-24-004906.xls View HTML
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004907.pdf 0001562180-24-004907.rtf 0001562180-24-004907.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax